Viewing Study NCT04406857


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2025-12-25 @ 4:32 PM
Study NCT ID: NCT04406857
Status: TERMINATED
Last Update Posted: 2025-02-26
First Post: 2020-05-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization: